Calcium acetate

Generic Name
Calcium acetate
Brand Names
Domeboro, Eliphos, Phoslo, Phoslyra, Procalamine 3
Drug Type
Small Molecule
Chemical Formula
C4H6CaO4
CAS Number
62-54-4
Unique Ingredient Identifier
Y882YXF34X
Background

The chemical compound calcium acetate is the calcium salt of acetic acid. It has been commonly referred to as the acetate of lime. The anhydrous form is very hygroscopic, therefore the monohydrate is the common form.

Indication

Calcium acetate is one of a number of calcium salts used to treat hyperphosphatemia (too much phosphate in the blood) in patients with kidney disease.

Associated Conditions
Hyperphosphataemia, High phosphate levels
Associated Therapies
Astringent, Prophylaxis of bacterial skin infections
Clinical Trials
Related News

Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

First Posted Date
2020-03-09
Last Posted Date
2020-10-08
Lead Sponsor
Akebia Therapeutics
Target Recruit Count
54
Registration Number
NCT04299633
Locations
🇨🇦

Research Site, Quebec, Canada

Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.

First Posted Date
2013-11-25
Last Posted Date
2017-02-06
Lead Sponsor
Medical Research Council
Target Recruit Count
30
Registration Number
NCT01991574
Locations
🇬🇧

MRC Human Nutrition Research, Cambridge, Cambridgeshire, United Kingdom

Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4

First Posted Date
2011-01-17
Last Posted Date
2016-01-14
Lead Sponsor
Albany College of Pharmacy and Health Sciences
Target Recruit Count
30
Registration Number
NCT01277497
Locations
🇺🇸

Albany Medical Center South Clinical Campus, Albany, New York, United States

Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)

First Posted Date
2010-06-03
Last Posted Date
2011-07-22
Lead Sponsor
Gulhane School of Medicine
Target Recruit Count
100
Registration Number
NCT01135615
Locations
🇹🇷

Gulhane School of Medicine, Ankara, Turkey

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD

First Posted Date
2008-11-05
Last Posted Date
2012-10-30
Lead Sponsor
Denver Nephrologists, P.C.
Target Recruit Count
148
Registration Number
NCT00785629
Locations
🇺🇸

Denver Nephrologists, PC, Denver, Colorado, United States

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate

First Posted Date
2006-08-15
Last Posted Date
2017-12-22
Lead Sponsor
Romanian Society of Nephrology
Registration Number
NCT00364000
Locations
🇷🇴

"Dr Carol Davila" Teaching Hospital of Nephrology, Bucharest, Romania

🇷🇴

"CI Parhon" Clinical Hospital, Iasi, Romania

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

First Posted Date
2005-09-21
Last Posted Date
2008-01-08
Lead Sponsor
Nabi Biopharmaceuticals
Target Recruit Count
203
Registration Number
NCT00211939
Locations
🇺🇸

University of Texas Health Sciences Center, San Antonio, Texas, United States

EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)

First Posted Date
2005-09-21
Last Posted Date
2008-01-08
Lead Sponsor
Nabi Biopharmaceuticals
Target Recruit Count
110
Registration Number
NCT00211978
Locations
🇺🇸

University of Texas Health Sciences Center, San Antonio, Texas, United States

Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals

Not Applicable
Completed
Conditions
Renal Failure
First Posted Date
2001-07-05
Last Posted Date
2005-06-24
Lead Sponsor
National Center for Research Resources (NCRR)
Registration Number
NCT00018135
Locations
🇺🇸

Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy